LB Pharmaceuticals Inc. - Form 8-K Filing

LB Pharmaceuticals Inc. announced that Zachary Prensky has notified the Board of Directors of his intent to retire and will not stand for reelection at the 2026 annual meeting of stockholders. His term as director will conclude at the meeting, and he will remain on the Board and the Nominating and Corporate Governance Committee until then. Mr. Prensky's departure is not due to any disagreements with the company. He is expected to provide consulting services and will continue to receive benefits as per the Transition Agreement Amendment, which also allows his outstanding stock options to continue vesting. This amendment modifies a previous agreement from November 26, 2024. The company expressed gratitude for Mr. Prensky's service and contributions.